Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    This updates the website’s displayed revision/version number from v3.5.0 to v3.5.3, reflecting a documentation or platform release rather than any change to the clinical trial content.
    Difference
    0.0%
    Check dated 2026-04-26T15:26:20.000Z thumbnail image
  3. Check
    23 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Added posted results data including incidence of dose-limiting toxicities, 18-month overall survival, and adverse events with time-to-event endpoints, and updated results reporting dates. Linked or updated study documents (protocol/consent forms) accompany the results.
    Difference
    2%
    Check dated 2026-03-29T00:31:04.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T19:09:39.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T08:41:52.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no substantive content changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:37:06.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The change consists only of a version revision tag, updating from v3.4.0 to v3.4.1, with no changes to study content or page functionality. To avoid being alert by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:36:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.